On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has announced a collaborat...
Cold storage infrastructure plays a critical role across the life sciences industry, safeguarding vaccin...
Eli Lilly and Company has announced a $500 million investment over five years to bolster South Korea’s pharmaceu...
UltraGreen.ai Limited, a global leader in fluorescence-guided surgery and digital health solutions, today announce...
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with Cyto-Fa...
National University of Singapore (NUS) Medicine is collaborating with DayOne, a Singapore-headquartered global data cent...
Hong Kong-based CK Life Sciences has announced the establishment of Sequencio Therapeutics, a wholly-owned subsidiary de...
Precision for Medicine, a global leader in biomarker-driven clinical research and development, has announced the opening...
Charles River Laboratories reinforced its commitment to strengthening the Asia Pacific biomanufacturing ecosystem by sig...
DayOne, a Singapore-headquartered global data center developer and operator and Cortical Labs, a biological computi...
Beijing Tsingke Biotech and iGeneTech Bioscience have announced a strategic partnership aimed at advancing the fiel...
The Bioinnovation APAC 2026 forum, held in Singapore on March 4-5, was a landmark event that brou...
Hangzhou Sciwind Biosciences has announced that China's National Medical Products Administration (NMPA) has approved Ecn...
Australia's Monash University has announced the award of support from the Advanced Research Projects Agency for Health (...
Terumo Blood and Cell Technologies (Terumo BCT) has announced the launch of its new cell & gene therapy (C&...
As global life sciences companies seek locations that combine skilled talent, scalable infrastructure, a...
Singapore-based startup ImmunoScape, an A*STAR spin-out backed by Amgen Ventures and EDBI that is developing next-genera...
MGI Tech Co., Ltd. , a company dedicated to developing core tools and technologies that drive innovation in the life sci...
Taiwan-based Senhwa Biosciences, Inc. has announced the signing of a major strategic Memorandum of Understanding (MoU) w...
A University of Melbourne industry collaboration has been awarded $2.1 million by the Australian Government to build a q...
ADCs are highly complex molecules that were initially developed to allow highly potent cytotoxic agents to be selectivel...
As Saudi Arabia accelerates its biotech ambitions, what specific infrastructure investments or technological advancement...
What strategic gaps in the Korean diagnostics market does this exclusive distribution agreement with Lucent Diagnostics ...
How is Miltenyi Biotec adapting its long-term strategy to meet the specific scientific and clinical demands of ASEAN mar...
China-based Frontier Biotechnologies Inc. has entered into an exclusive licensing agreement with GSK, a global biop...
Aicuris Anti-infective Cures AG has entered into a definitive agreement under which Japan's Asahi Kasei, through it...
South Korea-based SK bioscience has announced that together with IDT Biologika (IDT) and Australian biotechnology compan...
The InnoHK Centre for Neuromusculoskeletal Restorative Medicine (CNRM), established by The Chinese University of Hong Ko...
YD Bio Limited, biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic inn...
US-based Sarepta Therapeutics, Inc. has announced the commercial launch of ELEVIDYS (delandistrogene moxeparvovec) in Ja...
In this exclusive conversation with BioSpectrum Asia, Alexander Seyf, CEO and Co founder of Autolomous, ...
Japan-based Astellas Pharma and US-based startup Vir Biotechnology have entered into a global strategic collaboration to...
Hangzhou Sciwind Biosciences has announced a strategic commercialisation collaboration with Pfizer China for Ecnoglutide...
ImmunityBio, Inc., a commercial-stage immunotherapy company based in the US, has announced a partnership with Biopharma ...
US-based Catalent and South Korea-based S.Biomedics have announced a strategic partnership to support the development an...
Johnson & Johnson has announced more than $1 billion investment in a next generation cell therapy manufacturing faci...
After talks between India's Union Minister for Science and Technology (S&T) Dr Jitendra Singh and Australian&nb...
AusBiotech and Sydney‑based life sciences company creator Proto Axiom have signed a Memorandum of Understanding ...
The Ministry of Health and Welfare (MoHW), South Korea government, and the Korea Health Industry Development Institute (...
CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that through its in...
Madrigal Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on delivering novel therapeutics for metabo...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations gl...
China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to a...
Precision for Medicine, a global leader in biomarker-driven clinical research and development, has announced the opening...
Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...
A world-first clinical trial will test cancer vaccines designed specifically for children with advanced or treatment-res...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.39 b...
South Korea-based SK bioscience will advance a novel respiratory syncytial virus (RSV) monoclonal antibody (mAb) for glo...
Australia-based startup AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha the...
Researchers have opened a ‘window to the brain’ with a new diagnostic device that can tell how deadly brain ...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (I...
The Asian biopharma landscape is evolving rapidly and undergoing major shifts, expanding focus beyond generics and contr...
What was the scientific moment or data point that convinced you NK cell–derived extracellular vesicles could becom...
Singapore has one of the most advanced biotechnology industries. Singapore began building its biomedical sciences ecosys...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Duke-NUS Medical School in Singapore has noted the announcement by Boehringer Ingelheim of a Phase IIa clinica...
US-based AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company focused on the discovery and developme...
Dr. Peiqing Zhang, Scientific Director, Cytiva (Left) Dr. Timothy Tan, Associate Professor and Leading Investigator, NT...
To accelerate the co-development of Taiwan–U.S. startup ecosystems in artificial intelligence (AI), semiconductors...
AusBiotech welcomes the Australian Government's announcement, made by the Minister for Trade and Tourism, Senator the Do...
Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular imm...
China-based startup Zonsen PepLib Biotech Inc. has entered into a worldwide license agreement with Novartis for an undis...
Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic ...
US-based Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, has annou...
Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...
China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...
US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...
Avance Clinical, a full-service Australia headquartered contract research organisation (CRO) focused on accelerating cli...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
US-based startup Xellar Biosystems, a globally leading innovator in next-generation artificial intelligence (AI)- a...
Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmab...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
The Japanese government has stepped up efforts to strengthen its startup ecosystem, rolling out a series of initiatives ...
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the bio...
mRNA first entered the global spotlight during COVID-19, turning companies such as Moderna and BioNTech into household n...
The International Vaccine Institute (IVI) and the Korea Disease Control and Prevention Agency (KDCA), together with four...
China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.&n...
Researchers in Australia have developed a new antimalarial drug candidate designed to address the growing challenge of d...
Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...
Japan-based PRISM BioLab and US-based startup Talus Bioscience, Inc. have entered into a collaboration to discover novel...
China and US based Harbour BioMed has announced a multi-year, global strategic collaboration and license agreement ...
Galux, a South Korean biotech startup pioneering AI-driven protein therapeutics discovery, has signed a research agreeme...
MEDI&GENE, a South Korea-based biopharmaceutical company developing therapeutics for metabolic diseases, has entered...
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an e...
ADEL, Inc., a South Korea-based biopharmaceutical company dedicated to developing therapies for neurodegenerative diseas...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company headquartered ...
Japan-based Chugai Pharmaceutical has announced the establishment of a new partnering office in South San Francisco, US....
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology th...
Vietnam’s burgeoning tech ecosystem is poised to ignite a vibrant new era of cross-continental collaboration and i...
Singapore-based NUS Medicine’s Clinical Imaging Research Centre (CIRC), a leading academic centre for advanced mol...
The Research, Innovation and Enterprise 2030 (RIE2030) plan was endorsed at the 15th Research, Innovation and Enterprise...
